Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NantHealth Inc NHIQ

Healthcare Medical Devices
NantHealth, Inc. provides enterprise solutions that help businesses transform complex data into actionable insights. The Company is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it... see more

Recent & Breaking News (GREY:NHIQ)

7 Biotech And Healthcare Picks For 2017 From Cantor Fitzgerald

Benzinga.com  January 6, 2017

NantHealth to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 9

Business Wire December 19, 2016

NantHealth, Inc. Announces Pricing of $100 Million of 5.50% Convertible Notes

Business Wire December 16, 2016

NantHealth, Inc. Announces Proposed $100 Million Convertible Notes Offering

Business Wire December 15, 2016

NantHealth Expands Adoption of GPS CancerTM with New Florida Genomics Lab License and Successful Adoption by Florida Community Oncologists

Business Wire December 13, 2016

NantHealth, NantKwest and NantOmics Announce Availability of GPS Cancer™ and Phase I – III QUILT Trials Through the U.S. National Institutes of Health’s ClinicalTrials.gov

Business Wire December 8, 2016

NantHealth And TransMed Systems Partner to Enable and Inform Community Oncologists of the Most Effective Tools and Technologies for Personalized Cancer Treatments Using GPS Cancer™

Business Wire December 7, 2016

NantHealth Announces Exclusive Reseller Agreement for GPS Cancer™ with Oncotest-Teva in Israel

Business Wire December 6, 2016

NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Molecular Profiling to Patients in the Middle East Through Partnership with Lunatus

Business Wire December 5, 2016

NantHealth Reports 76% Increase in Total Q3 Net Revenue 2016 vs 2015, Gross Profit Triples

Business Wire November 7, 2016

NantHealth to Report 2016 Third-Quarter Financial Results and Host Conference Call on Monday, November 7

Business Wire November 4, 2016

NantHealth Announces Global Expansion of GPS Cancer; Partners with Sorgente to Expand Availability of GPS Cancer™ to Italy

Business Wire November 3, 2016

Cancer MoonShot 2020 Milestone: Announcing Launch of the Nation’s Largest Pediatric Brain Tumor Atlas

Business Wire October 28, 2016

NantHealth Expands GPS Cancer™ Coverage Through Partnership with Horizon Blue Cross Blue Shield of New Jersey and COTA

Business Wire October 27, 2016

NantHealth Announces Immunotherapy Clinical Trials in the Mid-Atlantic, First Whole Genomics Supercomputing Medical Reasoning Engine Helps Oncologists Make Informed Treatment Decisions for Cancer Patients

Business Wire October 26, 2016

NantHealth Partners with Children’s Hospital of Orange County to Revolutionize Pediatric Cancer Care Through the Use of GPS Cancer™

Business Wire September 21, 2016

Phoenix Children’s Hospital Selects NantHealth’s Molecular Testing Platform and Comprehensive Suite of Software Solutions for Precision Cancer Care

Business Wire September 7, 2016

NantHealth Reports Strong 2016 Second-Quarter Revenues and Continued Progress on GPS Cancer and NantOS Platform

Business Wire August 9, 2016

Sanford Health Selects NantHealth's eviti Platform to Deliver Efficient, Evidence-Based Oncology Decision Support for Treatment of Cancer Patients

Business Wire August 3, 2016

NantHealth to Report 2016 Second-Quarter Financial Results and Host Conference Call on Tuesday, August 9

Business Wire August 2, 2016